CytomX Therapeutics, Inc.
CTMX
$3.36
$0.010.30%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 330.28M | 346.71M | 137.05M | 143.63M | 158.09M |
| Total Receivables | 38.99M | 646.00K | 2.01M | 1.63M | 1.87M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 2.96M | 5.74M | 4.86M | 3.96M | 4.67M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 917.00K | -- | -- | -- | -- |
| Total Current Assets | 373.16M | 353.10M | 143.92M | 149.22M | 164.62M |
|
|
|||||
| Total Current Assets | 373.16M | 353.10M | 143.92M | 149.22M | 164.62M |
| Net Property, Plant & Equipment | 6.12M | 3.35M | 4.70M | 6.54M | 7.89M |
| Long-term Investments | 949.00K | 949.00K | 949.00K | 949.00K | 949.00K |
| Goodwill | 949.00K | 949.00K | 949.00K | 949.00K | 949.00K |
| Total Other Intangibles | 365.00K | 401.00K | 438.00K | 474.00K | 510.00K |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 641.00K | 1.56M | 1.56M | 1.08M | 1.08M |
| Total Assets | 381.23M | 359.36M | 151.57M | 158.25M | 175.06M |
|
|
|||||
| Total Accounts Payable | 1.94M | 1.37M | 1.30M | 646.00K | 227.00K |
| Total Accrued Expenses | 12.35M | 11.92M | 14.17M | 12.32M | 11.34M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.50M | 2.86M | 4.24M | 5.60M | 5.44M |
| Total Finance Division Other Current Liabilities | 24.07M | 17.88M | 26.90M | 22.47M | 22.21M |
| Total Other Current Liabilities | 24.07M | 17.88M | 26.90M | 22.47M | 22.21M |
| Total Current Liabilities | 39.86M | 34.02M | 46.62M | 41.03M | 39.22M |
|
|
|||||
| Total Current Liabilities | 39.86M | 34.02M | 46.62M | 41.03M | 39.22M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 4.21M | -- | -- | -- | 1.44M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 35.09M | 5.39M | 5.94M | 9.84M | 14.48M |
| Total Liabilities | 79.16M | 39.41M | 52.56M | 50.87M | 55.15M |
|
|
|||||
| Common Stock & APIC | 1.05B | 1.05B | 810.85M | 789.72M | 788.09M |
| Retained Earnings | -750.86M | -730.20M | -711.95M | -682.44M | -668.21M |
| Treasury Stock & Other | -196.00K | 102.00K | 111.00K | 104.00K | 33.00K |
| Total Common Equity | 302.07M | 319.94M | 99.01M | 107.39M | 119.91M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 302.07M | 319.94M | 99.01M | 107.39M | 119.91M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 302.07M | 319.94M | 99.01M | 107.39M | 119.91M |
|
|
|||||